They are integral allosteric membrane proteins comprising five identical or homologous subunits symmetrically arranged around a central ionic channel. The acetylcholine (ACh)-binding sites on the ...

Quanta is progressing three, chemically distinct, oral KRAS inhibitors targeting the most common mutations in KRAS. QTX3034 is an allosteric multi-KRAS inhibitor with G12D-preferring activity.